RecruitingNot ApplicableNCT04426214

Neuromodulation and Cognitive Training for Substance Use Disorders

Sponsor

University of Minnesota

Enrollment

80 participants

Start Date

Jul 16, 2021

Study Type

INTERVENTIONAL

Conditions

Alcohol Use Disorder Stimulant Use

Summary

The relapsing nature of substance use disorder is a major obstacle to successful treatment. About 70% of those entering treatment will relapse within one year. To improve treatment outcome, new interventions targeting the underlying brain biomarkers of relapse vulnerability hold significant promise in reducing this critical public health problem. This study is testing a new intervention, namely tDCS-Augmented Cognitive Training, to engage these brain biomarkers to improve cognition and improve treatment outcomes.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Cognitive Training and a medical device called tDCS for people with alcohol use disorder and stimulant use. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtDCS

We will apply tDCS in combination with cognitive training. All participants receive cognitive training, and will be randomized to receive either active or sham tDCS

BEHAVIORALCognitive Training

cognitive training on computer